Skip to main content

A PHASE 2A, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF IRL201104 IN ADULT PARTICIPANTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS (EOE)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Revolo Biotherapeutics

Start Date

January 25, 2022

End Date

January 24, 2025
 

Administered By

Medicine, Gastroenterology

Awarded By

Revolo Biotherapeutics

Start Date

January 25, 2022

End Date

January 24, 2025